Last updated: February 24, 2026
What Is the Drug Market for NDC 67457-0582?
NDC 67457-0582 corresponds to Laxapro (Escitalopram Oxalate), a selective serotonin reuptake inhibitor (SSRI) used to treat depression and anxiety disorders. It is marketed mainly as a generic product, with brand formulations such as Lexapro primarily in the U.S.
The drug faces competition from other SSRIs and atypical antidepressants, with a significant presence of generics since patent expiration in 2012. The primary market segments include outpatient mental health clinics, primary care providers, and institutional pharmacies.
How Large Is the Market?
The global antidepressant market was valued at approximately $13.8 billion in 2021. The U.S. accounts for roughly 68% of this, meaning a domestic market size estimated at $9.4 billion in 2021.
U.S. Market Share and Sales Data:
| Year |
Total Antidepressant Sales (USD billion) |
Lexapro-Related Sales (USD million) |
Market Share of Lexapro (Approximate) |
| 2019 |
10.8 |
1,150 |
10.6% |
| 2020 |
11.4 |
950 |
8.3% |
| 2021 |
13.8 |
700 |
5.1% |
Market shares of Lexapro declined post-generic entry in 2012, but it remains a notable player, especially among SSRIs.
Price Trends and Projections
Historical Pricing
- Brand Lexapro (prior to patent expiry): Approximate retail price per 20 mg tablet was USD 10–12.
- Generic Escitalopram (post-2012): Retail prices have fallen to USD 0.20–0.50 per 20 mg tablet.
Bulk purchasing prices (e.g., for pharmacies, hospitals) are significantly lower, often below USD 0.10 per tablet.
Current Pricing (2023)
- Brand (Lexapro): USD 12–15 per 20 mg tablet (retail). Insurance often covers significant portions.
- Generic (Escitalopram): USD 0.20–0.50 per tablet (retail). Wholesale acquisition cost (WAC) is generally below USD 0.10.
Price Projections (Next 3-5 Years)
Assuming market continues its downward trend for generics:
| Year |
Estimated Average Price per 20 mg Tablet |
Assumptions |
| 2023 |
USD 0.20 |
Stable, competitive generics dominate. |
| 2024 |
USD 0.20 |
No significant patent or exclusivity, prices stabilize. |
| 2025 |
USD 0.20 |
Market saturation limits price decreases. |
| 2026 |
USD 0.20 |
No new branded formulations entering the market. |
If new formulations or combination products enter, price adjustments may occur. However, current trends suggest stability at low price points for generics.
Competitive Landscape and Market Dynamics
- Patent Status: The patent for Lexapro expired in 2012, leading to an influx of generics.
- Generic Competition: Multiple manufacturers produce high-quality generics, driving prices down.
- Market Penetration: Brand sales predominantly through pharmacies with insurance coverage; generics placed in lower-cost channels.
- Regulatory Factors: Approval pathways for biosimilars or novel formulations could influence future pricing.
Key Price Influencers
- Drug approval and patent status: Delays or patent extensions influence exclusivity and pricing.
- Manufacturing costs: Lower manufacturing costs for generics decrease prices.
- Insurance formularies: Insurance coverage favors generic use, further reducing retail prices.
- Market demand: Increases in depression and anxiety prevalence sustain demand, though pricing is more affected by competitive entry.
Summary
The market for NDC 67457-0582 (Escitalopram) is mature with stable, low prices for generics. The U.S. market size for this drug remains significant, with annual sales declining as prices fall and market saturation occurs. No major price increases are forecasted barring new formulation approvals or patent litigations.
Key Takeaways
- The U.S. antidepressant market was valued at $13.8 billion in 2021, with SSRIs representing a major segment.
- Generic escitalopram prices have stabilized around USD 0.20–0.50 per tablet since patent expiry.
- Market share for the original brand Lexapro has decreased but remains relevant in branded prescriptions.
- Prices are unlikely to increase for the next five years unless new formulations or indications emerge.
- Future growth driven by demand for mental health therapies will have minimal impact on drug prices due to high generic competition.
FAQs
1. What factors could cause a price increase for NDC 67457-0582?
Introduction of a new branded formulation, patent litigations, or regulatory approvals for novel combinations could increase prices temporarily.
2. How does insurance coverage impact drug pricing?
Insurance plans typically favor generics, keeping out-of-pocket costs low for patients and influencing retail prices.
3. Are biosimilar or alternative products entering this market?
No biosimilars are relevant, as escitalopram is a small-molecule drug. However, new SSRI formulations or combination drugs could affect future pricing.
4. What is the outlook for brand-name Lexapro?
Brand sales remain primarily through prescriptions reimbursed by insurance, but generic sales dominate the market, reducing its share and profitability.
5. How does global demand influence the U.S. market?
US demand accounts for approximately 68% of the global antidepressant market. Global trends in mental health awareness could sustain or slightly grow demand, but prices are dictated primarily by supply-side competition.
References
- IQVIA. (2022). IQVIA National Sales Perspectives.
- Statista. (2022). Global antidepressant market size.
- FDA. (2012). Lexapro (escitalopram oxalate) patents and exclusivity.
- GoodRx. (2023). Drug prices and discounts.
- EvaluatePharma. (2022). Pharmaceutical market forecasts.
